437 related articles for article (PubMed ID: 9020272)
1. The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women.
Kedes DH; Ganem D; Ameli N; Bacchetti P; Greenblatt R
JAMA; 1997 Feb; 277(6):478-81. PubMed ID: 9020272
[TBL] [Abstract][Full Text] [Related]
2. Human herpesvirus 8 infection and Kaposi's sarcoma among human immunodeficiency virus-infected and -uninfected women.
Greenblatt RM; Jacobson LP; Levine AM; Melnick S; Anastos K; Cohen M; DeHovitz J; Young MA; Burns D; Miotti P; Koelle DM
J Infect Dis; 2001 Apr; 183(7):1130-4. PubMed ID: 11237842
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.
Lennette ET; Blackbourn DJ; Levy JA
Lancet; 1996 Sep; 348(9031):858-61. PubMed ID: 8826812
[TBL] [Abstract][Full Text] [Related]
4. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control study.
Wojcicki JM; Newton R; Urban MI; Stein L; Hale M; Patel M; Ruff P; Sur R; Bourboulia D; Sitas F
BMC Infect Dis; 2003 Sep; 3():21. PubMed ID: 12971827
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections.
Rezza G; Lennette ET; Giuliani M; Pezzotti P; Caprilli F; Monini P; Buttò S; Lodi G; Di Carlo A; Levy JA; Ensoli B
Int J Cancer; 1998 Jul; 77(3):361-5. PubMed ID: 9663596
[TBL] [Abstract][Full Text] [Related]
7. Sexual transmission and the natural history of human herpesvirus 8 infection.
Martin JN; Ganem DE; Osmond DH; Page-Shafer KA; Macrae D; Kedes DH
N Engl J Med; 1998 Apr; 338(14):948-54. PubMed ID: 9521982
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of human herpesvirus 8 and its association with Kaposi sarcoma in Brazil.
Zago A; Bourboulia D; Viana MC; Collandre H; Dietze R; Boshoff C; Keller R
Sex Transm Dis; 2000 Sep; 27(8):468-72. PubMed ID: 10987454
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996.
Melbye M; Cook PM; Hjalgrim H; Begtrup K; Simpson GR; Biggar RJ; Ebbesen P; Schulz TF
Int J Cancer; 1998 Aug; 77(4):543-8. PubMed ID: 9679756
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for Kaposi's sarcoma among HHV-8 seropositive homosexual men with AIDS.
Nawar E; Mbulaiteye SM; Gallant JE; Wohl DA; Ardini M; Hendershot T; Goedert JJ; Rabkin CS;
Int J Cancer; 2005 Jun; 115(2):296-300. PubMed ID: 15688390
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of HHV-8 antibodies in HIV-positive homosexual men without Kaposi's sarcoma and their clinical follow-up.
Verbeek W; Frankel M; Miles S; Said J; Koeffler HP
Am J Clin Pathol; 1998 Jun; 109(6):778-83. PubMed ID: 9620039
[TBL] [Abstract][Full Text] [Related]
12. HIV serodiscordant sex partners and the prevalence of human herpesvirus 8 infection among HIV negative men who have sex with men: baseline data from the EXPLORE Study.
Casper C; Carrell D; Miller KG; Judson FD; Meier AS; Pauk JS; Morrow RA; Corey L; Wald A; Celum C
Sex Transm Infect; 2006 Jun; 82(3):229-35. PubMed ID: 16731675
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for human herpesvirus 8 infection in a cohort of drug users in the Netherlands, 1985-1996.
Renwick N; Dukers NH; Weverling GJ; Sheldon JA; Schulz TF; Prins M; Coutinho RA; Goudsmit J
J Infect Dis; 2002 Jun; 185(12):1808-12. PubMed ID: 12085330
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic.
Osmond DH; Buchbinder S; Cheng A; Graves A; Vittinghoff E; Cossen CK; Forghani B; Martin JN
JAMA; 2002 Jan; 287(2):221-5. PubMed ID: 11779265
[TBL] [Abstract][Full Text] [Related]
15. Human herpesvirus 8 seroconversion in Kenyan women by enzyme-linked immunosorbent assay and immunofluorescence assay.
Chohan BH; Taylor H; Obrigewitch R; Lavreys L; Richardson BA; Mandaliya KN; Bwayo JJ; Kreiss JK; Morrow RA
J Clin Virol; 2004 Jun; 30(2):137-44. PubMed ID: 15125869
[TBL] [Abstract][Full Text] [Related]
16. Human herpesvirus 8 seroprevalence and evaluation of nonsexual transmission routes by detection of DNA in clinical specimens from human immunodeficiency virus-seronegative patients from central and southern Italy, with and without Kaposi's sarcoma.
Cattani P; Capuano M; Cerimele F; La Parola IL; Santangelo R; Masini C; Cerimele D; Fadda G
J Clin Microbiol; 1999 Apr; 37(4):1150-3. PubMed ID: 10074540
[TBL] [Abstract][Full Text] [Related]
17. Human herpesvirus-8 (HHV-8) antibodies in women from São Paulo, Brazil. Association with behavioral factors and Kaposi's sarcoma.
Caterino-De-Araujo A; de los Santos-Fortuna E; Carbone PH; Cibella SE; Moreira AA
Braz J Infect Dis; 2003 Dec; 7(6):395-401. PubMed ID: 14636479
[TBL] [Abstract][Full Text] [Related]
18. [Human herpesvirus-8 in Hungarian blood donors and in patients with Kaposi sarcoma].
Juhász A; Remenyik E; Hunyadi J; Gergely L
Orv Hetil; 1998 Dec; 139(50):3001-4. PubMed ID: 9876459
[TBL] [Abstract][Full Text] [Related]
19. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma.
Renwick N; Halaby T; Weverling GJ; Dukers NH; Simpson GR; Coutinho RA; Lange JM; Schulz TF; Goudsmit J
AIDS; 1998 Dec; 12(18):2481-8. PubMed ID: 9875587
[TBL] [Abstract][Full Text] [Related]
20. Human herpesvirus-8 seropositivity and clinical correlations in HIV-1-positive and highly exposed, persistently HIV-seronegative individuals in Greece.
Panayiotakopoulos GD; Mavroyianni D; Politou M; Aroni K; Kosmopoulou O; Kontos AN; Choremi-Papadopoulou H; Pediaditis J; Kordossis T
AIDS Patient Care STDS; 2005 Jun; 19(6):375-83. PubMed ID: 15989433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
